Application 209844
- Type
- NDA
- Sponsor
- CHARTWELL PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LYMEPAK | DOXYCYCLINE HYCLATE | TABLET;ORAL | EQ 100MG BASE | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209844-001 | LYMEPAK | DOXYCYCLINE HYCLATE | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N209844-001 | LYMEPAK | EQ 100MG BASE | TABLET / ORAL | RLD | 2018-06-15 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 294c6fc3-e7ca-46ea-b062-a27dd7b0bc97 | 2026-10-28 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline | DOXYCYCLINE | Chartwell RX LLC | 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | 2026-10-16 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | fbc1924f-d647-465a-b8b2-25de332c5896 | 2026-10-13 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Slate Run Pharmaceuticals, LLC | f31e69fc-e513-40e4-91b5-22ccf1ed9437 | 2026-10-09 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 656ccfe8-dd25-474a-9306-e44e511d7acd | 2026-10-06 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | c8194d6e-c407-465e-a342-4d2d9756dfc4 | 2026-10-02 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | d421b771-de88-4769-949f-8a24baa69c25 | 2026-09-16 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 051654c7-8ba6-44f2-842c-72f515e9b32d | 2026-09-15 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | HAWAII REPACK, INC | 88c429a1-351d-432e-b69b-d7a0afca482a | 2026-09-09 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 9ecadbc8-3087-4692-916a-b7f392d8e8da | 2026-09-09 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 5fdc01c3-c62f-40cf-8351-91cbcc43d379 | 2026-09-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | b0686eca-8bef-4e0d-a160-7b2c265f1b44 | 2026-09-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | df44c686-de34-487a-8741-a0a12993cab2 | 2026-08-27 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 2c29f716-bdb0-437d-92a4-d856b87db976 | 2026-08-26 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | NuCare Pharmaceuticals,Inc. | 0106a3d3-db4d-f6ee-e063-6294a90a25e9 | 2026-08-26 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | cff08863-7156-49d0-abbd-8f9274302886 | 2026-08-22 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline | DOXYCYCLINE HYCLATE | Acella Pharmaceuticals, LLC | 3fb9f5ad-90a2-4858-bc34-f800d8b2fa90 | 2026-08-18 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Major Pharmaceuticals | e7c14a8e-c713-4f03-94e8-1ec9ae077d4d | 2026-08-05 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 2305ab4a-7d08-41f6-9c39-c9b6835be389 | 2026-08-05 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | cf95b2ca-2cf8-49a8-8e3a-f9b0f5b2072c | 2026-07-29 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62135-596 | LymePak | Doxycycline Hyclate | Chartwell RX, LLC. | NDA | Current |
| 62135-596 | LymePak | Doxycycline Hyclate | Chartwell RX, LLC. | NDA | Current |
| 62135-596 | LymePak | Doxycycline Hyclate | Chartwell RX, LLC. | NDA | Current |
| 72336-596 | LymePak | Doxycycline Hyclate | LIFSA DRUGS LLC | NDA | Current |